SUMMIT THERAPEUTICS INC's ticker is SMMT and the CUSIP is 86627T108. A total of 42 filers reported holding SUMMIT THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $119,776 | +398.3% | 64,052 | +568.9% | 0.00% | – |
| Q2 2023 | $24,036 | -15.9% | 9,576 | -41.3% | 0.00% | – |
| Q1 2023 | $28,570 | -24.9% | 16,326 | +82.4% | 0.00% | – |
| Q4 2022 | $38,046 | +1802.3% | 8,952 | +431.6% | 0.00% | – |
| Q3 2022 | $2,000 | – | 1,684 | +717.5% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 206 | -97.9% | 0.00% | – |
| Q1 2022 | $24,000 | -53.8% | 9,794 | -49.3% | 0.00% | – |
| Q4 2021 | $52,000 | -8.8% | 19,311 | +68.0% | 0.00% | – |
| Q3 2021 | $57,000 | -12.3% | 11,493 | +32.3% | 0.00% | – |
| Q2 2021 | $65,000 | -73.8% | 8,690 | -79.4% | 0.00% | – |
| Q1 2021 | $248,000 | +406.1% | 42,262 | +306.8% | 0.00% | – |
| Q4 2020 | $49,000 | +390.0% | 10,390 | +246.3% | 0.00% | – |
| Q3 2020 | $10,000 | – | 3,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polar Capital Holdings Plc | 5,800,000 | $27,260,000 | 0.16% |
| Inscription Capital, LLC | 17,000 | $80,000 | 0.03% |
| ExodusPoint Capital Management, LP | 185,844 | $873,000 | 0.01% |
| HoyleCohen, LLC | 10,359 | $49,000 | 0.01% |
| Virtu Financial LLC | 10,835 | $51,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 3,783 | $18,000 | 0.00% |
| Renaissance Technologies | 253,212 | $1,190,000 | 0.00% |
| Baillie Gifford | 372,261 | $1,749,000 | 0.00% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 37,238 | $175,000 | 0.00% |
| BREWIN DOLPHIN LTD | 1,970 | $9,259 | 0.00% |